NVN1 (Stavzor 250 mg)

Generic Name: valproic acid

Pill imprint NVN1 has been identified as Stavzor 250 mg.

Stavzor is used in the treatment of seizure prevention; schizoaffective disorder; seizures; hyperekplexia; migraine prevention (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Stavzor 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for NVN1

Stavzor 250 mg NVN1
Stavzor
Generic Name:
valproic acid
Imprint:
NVN1
Strength:
250 mg
Color:
Orange
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Manufacturer:
JDS Pharmaceuticals LLC
National Drug Code (NDC):
68968-3250
Inactive Ingredients:
ammonia
gelatin
glycerin
methacrylic acid - methyl methacrylate copolymer (1:1)
triethyl citrate
water
FD&C Yellow No. 6

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)